FDA approves Revolution Medicines' first targeted drug for advanced pancreatic cancer

发生了什么

The drug, Rasonque, nearly doubled median overall survival compared with standard chemotherapy in a 500-patient trial

摘要按规则整理自下方来源原文

来源